The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth
Open accessPublished version of a preprint
Abstract
Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis. Treatment of HCC is complicated by the fact that the disease is often diagnosed at an advanced stage when it is no longer amenable to curative surgery, and current systemic chemotherapeutics are mostly inefficacious. Sirtuin 1 (SIRT1) is a class III histone deacetylase that is implicated in gene regulations and stress resistance. In this study, we found that SIRT1 is essential for the tumorigenesis of HCC. We showed that although SIRT1 was expressed at very low levels in normal livers, it was overexpressed in HCC cell lines and in a subset of HCC. Tissue microarray analysis of HCC and adjacent nontumoral liver tissues revealed a positive correlation between the expression levels of SIRT1 and advancement in tumor grades. Downregulation of SIRT1 consistently suppressed the proliferation of HCC cells via the induction of cellular senescence or apoptosis. SIRT1 silencing also caused telomere dysfunction–induced foci and nuclear abnormality that were clearly associated with reduced expressions of telomerase reverse transcriptase (TERT), and PTOP, which is a member of the shelterin complex. Ectopic expression of either TERT or PTOP in SIRT1-depleted cells significantly restored cell proliferation. There was also a positive correlation between the level of induction of SIRT1 and PTOP in human HCC. Finally, SIRT1-silencing sensitized HCC cells to doxorubicin treatment. Together, our findings reveal a novel function for SIRT1 in telomere maintenance of HCC, and they rationalize the clinical exploration of SIRT1 inhibitors for HCC therapy. Cancer Res; 71(12); 4138–49. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
The POT1-TPP1 telomere complex is a telomerase processivity factor.
Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R., & Lei, M. (2007) · Nature · doi:10.1038/nature05454 · Cited by 704
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002020 · Cited by 588
Sirtuins as potential targets for metabolic syndrome
Guarente, L. (2006) · Nature · doi:10.1038/nature05486 · Cited by 468
Telomerase modulates expression of growth-controlling genes and enhances cell proliferation
Smith, L. L., Coller, H. A., & Roberts, J. M. (2003) · Nature Cell Biology · doi:10.1038/ncb985 · Cited by 438
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation
Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S.-H. L., Watkins, D. N., Herman, J. G., & Baylin, S. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020040 · Cited by 387 · cited 1×
“RNAi-mediated silencing of SIRT1 genes resulted in growth arrest or apoptosis in some epithelial tumor cells (34), and reactivated tumor suppressor genes (35).”
BackgroundTargeting telomerase for cancer therapeutics
Shay, J. W., & Keith, W. N. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604209 · Cited by 171
Research works printed but not linked: 38
- El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 · DOI · Paper page
- But, 2008, Natural history of hepatitis-related hepatocellular carcinoma, World J Gastroenterol, 14, 1652, 10.3748/wjg.14.1652 · DOI · Paper page
- Greten, 2005, Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients, Br J Cancer, 92, 1862, 10.1038/sj.bjc.6602590 · DOI · Paper page
- Yeo, 2005, A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma, J Natl Cancer Inst, 97, 1532, 10.1093/jnci/dji315 · DOI · Paper page
- Blander, 2004, The Sir2 family of protein deacetylases, Annu Rev Biochem, 73, 417, 10.1146/annurev.biochem.73.011303.073651 · DOI · Paper page
- Michan, 2007, Sirtuins in mammals: insights into their biological function, Biochem J, 404, 1, 10.1042/BJ20070140 · DOI · Paper page
- Haigis, 2010, Mammalian sirtuins: biological insights and disease relevance, Annu Rev Pathol, 5, 253, 10.1146/annurev.pathol.4.110807.092250 · DOI · Paper page
- Oberdoerffer, 2008, SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging, Cell, 135, 907, 10.1016/j.cell.2008.10.025 · DOI · Paper page
- Palacios, 2010, SIRT1 contributes to telomere maintenance and augments global homologous recombination, J Cell Biol, 191, 1299, 10.1083/jcb.201005160 · DOI · Paper page
- El Ramy, 2009, Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes, Cell Mol Life Sci, 66, 3219, 10.1007/s00018-009-0105-4 · DOI
- Yuan, 2009, Histone H3-K56 acetylation is important for genomic stability in mammals, Cell Cycle, 8, 1747, 10.4161/cc.8.11.8620 · DOI · Paper page
- Wong, 2009, TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance, Int J Cancer, 124, 644, 10.1002/ijc.23968 · DOI · Paper page
- Tong, 2009, Inducible nucleosome depletion at OREBP-binding-sites by hypertonic stress, PLoS One, 4, e8435, 10.1371/journal.pone.0008435 · DOI
- Wong, 2005, Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo, Clin Cancer Res, 11, 6002, 10.1158/1078-0432.CCR-05-0209 · DOI
- Cheng, 2010, Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis, J Pathol, 220, 348, 10.1002/path.2644 · doi:10.1002/path.2644
- Law, 2010, Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis, Mol Cancer Ther, 9, 718, 10.1158/1535-7163.MCT-09-0700 · DOI
- Ota, 2006, Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells, Oncogene, 25, 176, 10.1038/sj.onc.1209049 · DOI · Paper page
- Pedeux, 2005, ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation, Mol Cell Biol, 25, 6639, 10.1128/MCB.25.15.6639-6648.2005 · DOI
- Palm, 2008, How shelterin protects mammalian telomeres, Annu Rev Genet, 42, 301, 10.1146/annurev.genet.41.110306.130350 · DOI · Paper page
- Kibe, 2010, Telomere protection by TPP1 is mediated by POT1a and POT1b, Mol Cell Biol, 30, 1059, 10.1128/MCB.01498-09 · DOI
- Xin, 2007, TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase, Nature, 445, 559, 10.1038/nature05469 · DOI · Paper page
- Wang, 2008, Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice, Cancer Cell, 14, 312, 10.1016/j.ccr.2008.09.001 · DOI · Paper page
- Bradbury, 2005, Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors, Leukemia, 19, 1751, 10.1038/sj.leu.2403910 · DOI · Paper page
- Huffman, 2007, SIRT1 is significantly elevated in mouse and human prostate cancer, Cancer Res, 67, 6612, 10.1158/0008-5472.CAN-07-0085 · DOI · Paper page
- Hida, 2007, Strong expression of a longevity-related protein, SIRT1, in Bowen's disease, Arch Dermatol Res, 299, 103, 10.1007/s00403-006-0725-6 · DOI · Paper page
- Cha, 2009, Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma, Clin Cancer Res, 15, 4453, 10.1158/1078-0432.CCR-08-3329 · DOI · Paper page
- Stünkel, 2007, Function of the SIRT1 protein deacetylase in cancer, Biotechnol J, 2, 1360, 10.1002/biot.200700087 · DOI · Paper page
- Ford, 2005, Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival, Cancer Res, 65, 10457, 10.1158/0008-5472.CAN-05-1923 · DOI · Paper page
- Heltweg, 2006, Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes, Cancer Res, 66, 4368, 10.1158/0008-5472.CAN-05-3617 · DOI · Paper page
- Olovnikov, 1973, A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon, J Theor Biol, 41, 181, 10.1016/0022-5193(73)90198-7 · doi:10.1016/0022-5193(73)90198-7
- Ozturk, 2008, Senescence and immortality in hepatocellular carcinoma, Cancer Lett
- Stewart, 2006, Telomeres: cancer to human aging, Annu Rev Cell Dev Biol, 22, 531, 10.1146/annurev.cellbio.22.010305.104518 · DOI · Paper page
- Ahmed, 2008, Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress, J Cell Sci, 121, 1046, 10.1242/jcs.019372 · DOI · Paper page
- Poncet, 2008, Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia, Blood, 111, 2388, 10.1182/blood-2007-09-111245 · DOI
- Cookson, 2009, The levels of telomere-binding proteins in human tumours and therapeutic implications, Eur J Cancer, 45, 536, 10.1016/j.ejca.2008.11.014 · DOI
- Veldman, 2004, Loss of hPot1 function leads to telomere instability and a cut-like phenotype, Curr Biol, 14, 2264, 10.1016/j.cub.2004.12.031 · DOI
- Barrientos, 2008, Distinct functions of POT1 at telomeres, Mol Cell Biol, 28, 5251, 10.1128/MCB.00048-08 · DOI
- Liu, 2009, The critical role of the class III histone deacetylase SIRT1 in cancer, Cancer Res, 69, 1702, 10.1158/0008-5472.CAN-08-3365 · DOI · Paper page
Cited by
The NAD metabolome — a key determinant of cancer cell biology
Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3340 · Cited by 639
Seven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
Xiong, H., Ni, Z., He, J., Jiang, S., Li, X., He, J., Gong, W., Zheng, L., Chen, S., Li, B., et al. (2017) · Oncogene · doi:10.1038/onc.2016.521 · Cited by 362
Emerging roles of SIRT1 in fatty liver diseases
Ding, R.-B., Bao, J., & Deng, C.-X. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19370 · Cited by 359
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 294
Metadata
- Authors
- Chen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., Yu, J., Ng, H.-K., Ling, M.-T., Huang, A.-L., Cai, X.-F., & Ko, B. C. B.
- Venue
- Cancer Research
- Published
- 2011-06-14
- Volume
- 71
- Issue
- 12
- Pages
- 4138-4149
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2170096414
- Cited by
- 188
- References
- 11
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-4274
- The paper
- Chen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., Yu, J., Ng, H.-K., Ling, M.-T., Huang, A.-L., Cai, X.-F., & Ko, B. C. B. (2011). Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-4274
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.